U.S. federal trademark · Serial No. 75355340 · Reg. No. 2117784
chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations
material treatment, namely, chemical synthesis for others featuring the development of a process to manufacture ingredients or finished biochemical products for applications in biotechnology
clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acid for a system delivering genes to non-dividing cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, leukemia and bodily conditions associated with impaired immunosystem
scientific and medical research and development, medical services; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.